Medical Care of the Early Stroke Patient

1. Davidson DLW Harden RM . Stroke. London: The Update Group, 1983.

2. Editorial. Management of stroke: 12 hours to 2 months. Drug Ther Bull 1985; 23: 9–12.

3. Sterman AB Furlan AJ Pessin M Kase C Caplan L Williams G . Acute stroke therapy trials: an introduction to recurring design issues. Stroke 1987; 18: 524–27.

4. Oxbury JM . Today's treatment. Diseases of the central nervous system: treatment of stroke. Br Med J 1975; 4: 450–52.

5. Thomas DJ . Treatment of acute stroke (editorial). Br Med J 1984; 288: 2–3.

6. Wise RJS Bernardi S Frackowiak RSJ Legg NJ Jones T . Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain 1983; 106: 197–222.

7. Skinhøj E Paulson OB . The mechanism of action of aminophylline upon cerebral vascular disorders. Acta Neurol Scand 1970; 46: 129–40.

8. Paulson OB . Regional cerebral blood flow in cerebral infarction and in transient ischemic attacks. Rev Electroenceph Neurophysiol Clin 1974; 4: 210–16.

9. Kusunoki M Kimura K Nakamura M . Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1981; 1: 413–17.

10. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983; 14: 668–76.

11. Furlan AJ Cavalier SJ Hobbs RE Weinstein MA Modic MT . Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology 1982; 32: 280–82.

12. Koller RL . Recurrent embolic cerebral infarction and anticoagulation. Neurology 1982; 32: 283–85.

13. Lodder J van der Lugt PJM . Evaluation of the risk of immediate anticoagulation treatment in patients with embolic stroke of cardiac origin. Stroke 1983; 14: 42–46.

14. Shields RW Jr Laureno R Lachman T . Anticoagulant-induced hemorrhage in acute cerebral embolism (abstract). Ann Neurol 1982; 12: 75.

15. Dyken ML . Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke. Neurol Clin 1983; 1: 223–42.

16. Duke RJ Bloch RF Turpie AGG Trebilcock R Bayer N . Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Int Med 1986; 105: 825–28.

17. Ramirez-Lassepas M Quiñones MR Nino HH . Treatment of acute ischemic stroke. Open trial with continuous intravenous heparinization. Arch Neurol 1986; 43: 386–90.

18. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 1984; 15: 779–89.

19. Cerebral Embolism Study Group. Cardioembolic stroke, early anticoagulation and brain hemorrhage. Arch Int Med 1987; 147: 636–40.

20. Gallus AS . The use of antithrombotic drugs in artery disease. Clin Haematol 1986; 15: 509–59.

21. Sherman DG Dyken ML Fisher M Harrison MJG Hart RG . Cerebral embolism. Chest 1986; 89 (Suppl): 82S–98S.

22. Ockelford P . Heparin 1986. Indications and effective use. Drugs 1986; 31: 81–92.

23. Leon-Sotomayor L . A new technique in the treatment of thromboembolic stroke. Preliminary report. Angiology 1980; 31: 729–43.

24. van der Molen HR . Vasoactive intraarterial therapy in peripheral occlusive arterial disease (with follow-up after 6.5 years). Angiology 1980; 31: 221–29.

25. Abe T . Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis. Folia Haematol, Leipzig 1986; 113: 122–36.

26. Fujishima M Omae T Tanaka K Iino K Matsuo O Mihara H . Controlled trial of combined urokinase and dextran sulphate therapy in patients with acute cerebral infarction. Angiology, 1986; 37: 487–98.

27. Fletcher AP Alkjaersig N Lewis M . A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7: 135–42.

28. Hallenbeck JM Furlow TW Jr . Prostaglandin I2 and indomethacin prevent impairment of postischemic brain reperfusion in the dog. Stroke 1979; 10: 629–37.

29. Gryglewski RJ Nowak S Kostka-Trabka E . Treatment of ischaemic stroke with prostacyclin. Stroke 1983; 14: 197–202.

30. Huczynski J Kostka-Trabka E Sotowska W . Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke. Stroke 1985; 16: 810–14.

31. Martin JF Hamdy N Nicholl J . Double-blind controlled trial of prostacyclin in cerebral infarction. Stroke 1985; 16: 386–90.

32. Miller VT Coull BM Yatsu FM Shah AB Beamer NB . Prostacyclin infusion in cerebral infarction. Neurology 1984; 34: 1431–35.

33. Hakim AM Pokrupa RP Wolfe LS . Preliminary report on the effectiveness of prostacyclin in stroke (abstract). Can J Neurol Sci 1984; 11: 409.

34. Hsu CY Faught RE Jr Furlan AJ . Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial. Stroke 1987; 18: 352–58.

35. Moncada S . Biology and therapeutic potential of prostacyclin. Stroke 1983; 14: 157–68.

36. Geismar P Marquardsen J Sylvest J . Controlled trial of intravenous aminophylline in acute cerebral infarction. Acta Neurol Scand 1976; 54: 173–80.

37. Britton M de Faire U Helmers C Miah K Rane A . Lack of effect of theophylline on the outcome of acute cerebral infarction. Acta Neurol Scand 1980; 62: 116–23.

38. Allen GS Ahn HS Preziosi TJ . Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619–24.

39. Gelmers HJ . The effects of nimodipine on the clinical course of patients with acute ischemic stroke. Acta Neurol Scand 1984; 69: 232–39.

40. Gelmers HJ . Effect of calcium antagonists on the cerebral circulation. Amer J Cardiol 1987; 59: 173B–76B.

41. Mitchell AD Steiner TJ . Nimodipine — a calcium antagonist in stroke therapy? In: Greenhalgh RM Rose F Clifford eds. Progress in stroke research 2. London: Pitman, 1983: 315–23.

42. Admani AK . New approach to treatment of recent stroke. Br Med J 1978; 2: 1678–79.

43. Steiner TJ Rose F Clifford . Randomized double-blind placebo-controlled clinical trial of naftidrofuryl in hemiparetic CT-proven acute cerebral hemisphere infarction. Roy Soc Med Internat Congr Symp Series 1986; 99: 85–98.

44. Steiner TJ Rose F Clifford . Towards a model stroke trial. The single-centre naftidrofuryl study. Neuroepidemiology 1986; 5: 121–47.

45. Steiner TJ Rose F Clifford . Naftidrofuryl. In: Rose F Clifford ed Advances in stroke therapy. New York: Raven Press, 1982: 71–77.

46. Turčáni P Bartko D . On the role of blood platelets in pathogenesis of ischemic brain edema. Proceedings of 5th European Workshop on Clinical Neuropharmacology, Bratislava, July 6th–8th 1987. London: John Libbey (in press).

47. Janssen PAJ . Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night? J Roy Soc Med 1987; 80: 409–13.

48. Davies PTG Steiner TJ . Naftidrofuryl fumarate on human platelet behaviour and evidence for a selective inhibition of 5–HT2 receptors. Proceedings of 5th European Workshop on Clinical Neuropharmacology, Bratislava, July 6th–8th 1987. London: John Libbey (in press).

49. Weintraub MI . Methysergide (Sansert) treatment in acute stroke. Community pilot study. Angiology 1985; 36: 137–42.

50. Fanciullacci M Granchi G Sicuteri F . Ergotamine and methysergide as serotonin partial agonists in migraine. Headache 1976; 16: 226–31.

51. Ramirez-Lassepas M Patrick BK Snyder BD Lakatua DJ . Failure of central nervous system serotonin blockage to influence outcome in acute cerebral infarction. A double blind randomized trial. Stroke 1986; 17: 953–56.

52. Grotta JC . Hemodilution in acute stroke (letter). Stroke 1986; 17: 332.

53. Toole JG Sandage BW Jr . Hemodilution in acute stroke (letter) Stroke 1986; 17: 332.

54. Italian Acute Stroke Study Group. The Italian hemodilution trial in acute stroke. Stroke 1987; 18: 670–76.

55. Strand T Asplund K Eriksson S Hägg E Lithner F Wester P-O . A randomized controlled trial of hemodilution therapy in acute ischemic stroke. Stroke 1984; 15: 980–89.

56. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke — background and study protocol. Stroke 1985; 16: 885–90.

57. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Stroke 1987; 18: 691–99.

58. Asplund K . Hemodilution in acute stroke (letter). Stroke 1986; 17: 332.

59. Hossmann V Heiss W-D Bewermeyer H Wiedemann G . Controlled trial of ancrod in ischemic stroke. Arch Neurol 1983; 40: 803–808.

60. Editorial. Steroids in haemorrhagic stroke. Lancet 1987; ii: 547–48.

61. Norris JW Hachinski VC . High dose steroid treatment in cerebral infarction. Br Med J 1986; 292: 21–23.

62. Norris JW . Steroid therapy in acute cerebral infarction. Arch Neurol 1976; 33: 69–71.

63. Fishman RA . The pathophysiology and treatment of brain edema. In: Matthews WB Glaser GH eds Recent advances in clinical neurology, volume 2. Edinburgh: Churchill Livingstone, 1978: 119–27.

64. Maxwell RE Long DM French LA . The clinical effects of a synthetic glucocorticoid used for brain edema in the practice of neurosurgery. In: Reulen JH Schürmann K eds Steroids and brain edema. Berlin: Springer-Verlag, 1972: 219–32.

65. Dyken M White PT . Evaluation of cortisone in the treatment of cerebral infarction. J Amer Med Assoc 1956; 162: 1531–34.

66. Bauer RB Tellez H . Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 1973; 4: 547–55.

67. Patten BM Mendell J Bruun B Curtin W Carter S . Double blind study of the effects of dexamethasone on acute stroke. In: Reulen HJ Schürmann K eds Steroids and brain edema. Berlin: Springer-Verlag, 1972: 259–66.

68. Wright WB . High-dosage dexamethasone in treatment of strokes in the elderly. Geront Clin 1974; 16: 88–91.

69. Kaste M Fogelholm R Waltimo O . Combined dexamethasone and low-molecular-weight dextran in acute brain infarction: double-blind study. Br Med J 1976; 2: 1409–10.

70. Mulley G Wilcox RG Mitchell JRA . Dexamethasone in acute stroke. Br Med J 1978; 2: 994–96.

71. Poungvarin N Bhoopat W Viriyavejakul A . Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987; 316: 1229–33.

72. Bayer AJ Pathy MSJ Newcombe R . Double-blind randomized trial of intravenous glycerol in acute stroke. Lancet 1987; i: 405–408.

73. Fawer R Justafré JC Berger JP Schelling JL . Intravenous glycerol in cerebral infarction: a controlled 4-month trial. Stroke 1978; 9: 484–86.

74. Steiner TJ Rose F Clifford . Trials in acute stroke (letter) Lancet 1987; i: 1032.

75. Frei A Cottier C Wunderlich P Lüdin E . Glycerol and dextran combined in the therapy of acute stroke. A placebo-controlled double-blind trial with a planned interim analysis. Stroke 1987; 18: 373–79.

76. Michenfelder JD Milde JH Sundt TM . Cerebral protection by barbiturate anesthesia. Arch Neurol 1976; 33: 345–50.

77. Lafferty JJ Keykhah MM Shapiro HM Van Horn K Behar MG . Cerebral hypometabolism obtained with deep pentobarbital anesthesia and hypothermia (30C). Anesthesiology 1978; 49: 159–64.

78. Aitkenhead A . Cerebral protection. Br J Hosp Med 1986; 35: 290–98.

79. Pappas TN Mironovich RO . Barbiturate-induced coma to protect against cerebral ischemia and increased intracranial pressure. Amer J Hosp Pharm 1981; 38: 494–98.

80. Yatsu FM . Protective effects of barbiturates on cerebral ischemia. In: McLaurin RL ed Head injuries. New York: Grune and Stratton, 1976: 185–87.

81. Rockoff MA Marshall LF Shapiro HM . High dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol 1979; 6: 194–99.

82. Smith AL Hoff JT Nielsen SL . Barbiturate protection in acute focal cerebral ischemia. Stroke 1974; 5: 1–7.

83. Marshall LF Smith RW Shapiro HM . Barbiturate control in intracerebral hypertension in head injury and other conditions: iatrogenic coma. Acta Neurol Scand 1977; 64 (Suppl): 156–57.

84. Marshall LF Smith RW Shapiro HM . The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J Neurosurg 1979; 50: 26–30.

85. Hägerdal M Welsh KA Keykhah MM Perez E Harp JR . Protective effects of combinations of hypothermia and barbiturates in cerebral hypoxia in the rat. Anesthesiology 1978; 49: 165–69.

86. Baskin DS Hosobuchi Y . Naloxone reversal of ischaemic neurological deficits in man. Lancet 1981; ii: 272–75.

87. Faden AI Hallenbeck JM Brown CQ . Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone. Neurology (NY) 1982; 32: 1083–87.

88. Anagnostou CN Gardiner IM de Belleroche JS Steiner TJ . Release of beta-endorphin into cerebrospinal fluid following cerebral infarction in the conscious rat: time course and effect of naloxone (abstract). J Cereb Blood Flow Metab 1987; 7 (Suppl 1): S178.

89. Bredesen DE Cutler JR Simon RP . Failure of naloxone to reverse vascular neurologic deficit (abstract). Neurology (NY) 1982; 32: A79.

90. Jabaily J Davis JN . Naloxone administration to patients with acute stroke. Stroke 1984; 15: 36–39.

91. Fallis RJ Fisher M Lobo RA . A double blind trial of naloxone in the treatment of acute stroke. Stroke 1984; 15: 627–29.

92. Woollard ML Pearson RM Dorf G Griffith D James IM . Controlled trial of ornithine alpha ketoglutarate (OAKG) in patients with stroke. Stroke 1978; 9: 218–22.

93. Hares P James IM Pearson RM . Effect of ornithine alpha ketoglutarate (OAKG) on the response of brain metabolism to hypoxia in the dog. Stroke 1978; 9: 222–24.

94. Dekoninck WJ Jocquet P Jacquy J Henriet M . Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneim-Forsch 1978; 28: 1654–57.

95. Warlow C Ogston D Douglas AS . Venous thrombosis following strokes. Lancet 1972; i: 1305–06.

96. Warlow C Ogston D Douglas AS . Deep venous thrombosis of the legs after strokes. Part I: incidence and predisposing factors. Br Med J 1976; 1: 1178–81.

97. McCarthy ST Robertson D Turner JJ Hawkey CJ . Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 1977; ii: 800–801.

98. Turpie AGG Levine MN Hirsh J . Double-blind randomized trial of ORG 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1987; i: 523–26.

99. Mellbring G Strand T Eriksson S . Venous thromboembolism after cerebral infarction and the prophylactic effect of dextran 40. Acta Med Scand 1986; 220: 425–29.

100. Bassi S Albizzati MG Sbacchi M Frattola L Massarotti M . Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke. J Neurosci Res 1984; 12: 493–98.

101. Frithz G Werner I . Studies on cerebrovascular strokes. Acta Med Scand 1976; 199: 133–40.

102. Sandercock P . Important new treatments for acute ischaemic stroke? (editorial). Br Med J 1987; 295: 1224–25.